Overall rank by patents
#11,470
of 50,000 tracked assignees
USPTO PatentsView assignee record - 27 granted patents across 32 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
The verdict
According to USPTO PatentsView, THE ranks #11,470 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 32 technology areas.
THE CITY University OF NEW YORK has been granted 27 US utility patents between 2015 and 2024, placing THE CITY University OF NEW YORK at #11,470 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 32 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.5 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, THE CITY University OF NEW YORK is one of the more focused assignees in the PatentsView dataset. By volume, THE sits between Techno-umg Co., Ltd. (27 patents, rank #11,456) and THL Holding Company, Llc (27 patents, rank #11,464) - the closest US assignees by grant volume. The composite Innovation Score of 44.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 1 grants, compared with 26 in the 2015–2019 window, a -96% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. THE CITY University OF NEW YORK's 17.5 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 32 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
TECHNO-UMG CO., LTD.
27 patents
TEFAL
27 patents
TEGO, INC.
27 patents
TEREX GB LIMITED
27 patents
THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION
27 patents
THE MCLEAN HOSPITAL CORPORATION
27 patents
THINK LABORATORY CO., LTD.
27 patents
THL Holding Company, LLC
27 patents
THE CITY UNIVERSITY OF NEW YORK
27 patents
What this shows THE holds 27 patents at rank #11,460, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,460 in granted patent volume.
Other assignees with the most granted patents in THE's primary technology class.
THE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 11.1% |
| 2016 | 9 | 33.3% |
| 2017 | 8 | 29.6% |
| 2018 | 3 | 11.1% |
| 2019 | 3 | 11.1% |
| 2024 | 1 | 3.7% |
Top 15 of 32 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#11,470
of 50,000 tracked assignees
44.2 out of 100
How to use this portfolio
THE's 27 grants land it in the top 26% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.